glp-1 compounding crackdown news october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our GLP-1 Shortage = Over -
Description
Ayrca, kardiyovaskler riskinin azaltlmasna da yardmc olabilir

The bottom line GLP-1s are very popular, with many healthcare professionals prescribing them to patients for the treatment of Type 2 diabetes, weight loss, and other conditions

doi: 10.1016/S0140-6736(21)02188-7 74 BattelinoTBergenstalRMRodrguezAFernndez LandLBrayRTongZet al

This shames the patients

Systemic inflammation, mediated by cytokines like IL-6 and TNF-, can affect vagal tone and enteric signaling in ways that mimic GLP-1 action, particularly delayed gastric emptying and nausea [6-8]
Prospective studies provide stronger evidence than observational studies because they follow subjects over time, rather than looking back